Calgary, Alberta–(Newsfile Corp. – June 15, 2022) – NurExone Biologic Inc. (formerly, EnerSpar Corp.) (TSXV: NRX) (the “Company“) is pleased to announce that it has completed its previously announced business combination transaction (the “Transaction“) with NurExone Biologic Ltd. (“NurExone“). read more
